Real-World Intravitreal Aflibercept 2 mg Treatment of Macular Oedema Secondary to Retinal Vein Occlusion in Italy: 24-Month Results from the AURIGA Observational Study
Robust VA improvements were observed in treatment-naïve patients with RVO in Italy following IVT-AFL treatment for up to 24 months in routine practice, despite a low injection frequency. However, guidelines indicate that regular, proactive treatment beyond the acute stage is required to improve long-term outcomes. .
Authors
- Monica Varano (ORCID: https://orcid.org/0000-0002-6530-1563)
- Tobias Machewitz
- Helmut Allmeier (ORCID: https://orcid.org/0000-0002-5165-4851)
- Maria Oliva Grassi (ORCID: https://orcid.org/0000-0002-5952-7910)
- Maria Vadalà (ORCID: https://orcid.org/0000-0002-2726-698X)
- Andrea Russo (ORCID: https://orcid.org/0000-0002-7725-5971)
Institutions
- University of Catania (IT)
- Fondazione G.B. Bietti (IT)
- Bayer (Switzerland) (CH)
- Policlinico Universitario di Catania (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- Istituto Euro Mediterraneo di Scienza e Tecnologia (IT)
- University of Bari Aldo Moro (IT)
- Bayer (Germany) (DE)
- University of Palermo (IT)
Publication Details
- Journal
- Ophthalmologica
- Published
- 2025-04-09
- DOI
- https://doi.org/10.1159/000545534
- Citations
- 1
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.71